Apogee Therapeutics Inc. News

Latest updates and market news for APGE

6 news

Mar 1 - Mar 7, 2026

Page 1

Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing

Motley Fool

3 days ago

Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing

Apogee Therapeutics Teases 52-Week Zumi Durability Data, Phase III Path at TD Cowen Conference

MarketBeat

3 days ago

Apogee Therapeutics Teases 52-Week Zumi Durability Data, Phase III Path at TD Cowen Conference

Is Rising R&D Spend And New Equity Shelf Altering The Investment Case For Apogee Therapeutics (APGE)?

Simply Wall St.

3 days ago

Is Rising R&D Spend And New Equity Shelf Altering The Investment Case For Apogee Therapeutics (APGE)?

MT Newswires

4 days ago

RBC Lowers Price Target on Apogee Therapeutics to $82 From $83, Keeps Sector Perform, Speculative Risk

MT Newswires

5 days ago

Wedbush Adjusts Price Target on Apogee Therapeutics to $95 From $90, Maintains Outperform Rating

📈

AI Sentiment

Highly Positive

8/10

Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results

GlobeNewswire

5 days ago

Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results

📈

AI Sentiment

Highly Positive

8/10

Share this news page

Share on Social Networks: